No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs372958799 |
chr7:64361830-64361831 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs375115436 |
chr7:64361842-64361843 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs548878400 |
chr7:64361856-64361857 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs372514205 |
chr7:64361860-64361861 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs144892163 |
chr7:64361894-64361895 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs10264026 |
chr7:64361941-64361942 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
7 |
rs552491587 |
chr7:64361995-64361996 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs76897101 |
chr7:64362005-64362006 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs531348903 |
chr7:64362007-64362008 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs10282599 |
chr7:64362012-64362013 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs568184583 |
chr7:64362031-64362032 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs191187005 |
chr7:64362100-64362101 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs147963145 |
chr7:64362109-64362110 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs185728748 |
chr7:64362130-64362131 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs539694804 |
chr7:64362155-64362156 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs562346624 |
chr7:64362158-64362159 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs190588188 |
chr7:64362167-64362168 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs1966140 |
chr7:64362191-64362192 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs542228783 |
chr7:64362196-64362197 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs372404709 |
chr7:64362297-64362298 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs370122710 |
chr7:64362312-64362313 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs571182183 |
chr7:64362324-64362325 |
Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs184439766 |
chr7:64362326-64362327 |
Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs181762968 |
chr7:64362437-64362438 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs373120486 |
chr7:64362491-64362492 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs114415327 |
chr7:64362606-64362607 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs376289019 |
chr7:64362650-64362651 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs545741341 |
chr7:64362721-64362722 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs547224617 |
chr7:64362772-64362773 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs562819957 |
chr7:64362832-64362833 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs531182190 |
chr7:64362833-64362834 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs10237833 |
chr7:64362836-64362837 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs141522814 |
chr7:64362933-64362934 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs62455117 |
chr7:64362965-64362966 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs185105441 |
chr7:64363005-64363006 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs571014319 |
chr7:64363038-64363039 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs115028737 |
chr7:64363043-64363044 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs550179606 |
chr7:64363071-64363072 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs113632881 |
chr7:64363092-64363093 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs112787709 |
chr7:64363093-64363094 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs370123740 |
chr7:64363101-64363102 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs570307016 |
chr7:64363127-64363128 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs143676234 |
chr7:64363131-64363132 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs569965560 |
chr7:64363161-64363162 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs148111502 |
chr7:64363207-64363208 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs572154903 |
chr7:64363273-64363274 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs377508456 |
chr7:64363287-64363288 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs71567877 |
chr7:64363298-64363299 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs4717223 |
chr7:64363299-64363300 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs200788266 |
chr7:64363303-64363304 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|